Center for a Livable Future Statement on
The Preservation of Antibiotics for Medical Treatment Act (PAMTA).
Washington, D.C. (July 15, 2009) – The Johns Hopkins Center for a Livable Future (CLF) Director Robert Lawrence, MD, issued the following statement today regarding recent Congressional action on the issue of antibiotic resistance.
“On Monday, the U.S. House of Representatives held its first hearing this session on the important issue of antibiotic resistance. The Center for Livable Future (CLF) applauds the leadership of Rules Committee Chairwoman Louise Slaughter (D-NY) and her colleagues to support the increasingly critical public health recommendations put forward in the Preservation of Antibiotics for Medical Treatment Act (H.R. 1549/S. 619).”
“A panel of experts from the U.S. Food and Drug Administration, science and business communities spoke at the hearing about the need to end non-therapeutic use of antibiotics as growth promoters in the production of food animals. The increase we continue to see in antibiotic-resistant bacteria is a major threat to the health of the public, and policymakers should move to phase out and ban the use of antimicrobials for non-therapeutic use in food animal production. PAMTA serves to curtail such use, instead saving antibiotics for therapeutic purposes only.”